News

Lifestyle Meets E-Commerce: Launch Vector’s Model for Digital Wealth
In a world where side hustles and passive income are the new status symbols, Launch Vector is turning heads with a ...
AAVantgarde Receives FDA Clearance to Progress Stargardt Disease Asset, AAVB-039, into CELESTE, a Phase 1/2 Clinical Trial
AAVB-039 delivers the full-length ABCA4 -protein, addressing the root cause of the disease and enabling treatment of all patients, independent of mutationCELESTE is informed by the STELLA prospective ...